Werbung
Werbung
RKDA
Arcadia Biosciences, Inc.
2.66
USDGesponsert
-0.09
-3.27%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
2.75
+0.09
+3.38%
RKDA Ergebnisberichte
Positives Überraschungsverhältnis
RKDA übertreffen die 22 der letzten 38Schätzungen.
58%
Nächster Bericht
Datum des nächsten Berichts
18. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.43M
/-$0.67
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+9.68%
/-208.06%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+17.43%
/-77.59%
Arcadia Biosciences, Inc. earnings per share and revenue
On 07. Nov. 2025, RKDA reported earnings of 0.62 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 212.56% surprise. Revenue reached 1.30 million, compared to an expected 1.94 million, with a -32.82% difference. The market reacted with a -2.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.67 USD, with revenue projected to reach 1.43 million USD, implying an decrease of -208.06% EPS, and increase of 9.68% in Revenue from the last quarter.
FAQ
What were Arcadia Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Arcadia Biosciences, Inc. reported EPS of $0.62, beating estimates by 212.56%, and revenue of $1.30M, -32.82% below expectations.
How did the market react to Arcadia Biosciences, Inc.'s Q3 2025 earnings?
The stock price moved down -2.17%, changed from $3.69 before the earnings release to $3.61 the day after.
When is Arcadia Biosciences, Inc. expected to report next?
The next earning report is scheduled for 18. März 2026.
What are the forecasts for Arcadia Biosciences, Inc.'s next earnings report?
Based on 3
analysts, Arcadia Biosciences, Inc. is expected to report EPS of -$0.67 and revenue of $1.43M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung